The PROTECT-HIE Pilot Trial
NCT07406477
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Hypoxic-ischemic Encephalopathy (HIE)
Interventions
DRUG:
Dobutamine
DIAGNOSTIC_TEST:
TnECHO
Sponsor
University of Alberta